Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: The role of rs67491583

Academic Article

Abstract

  • Recent genome-wide association studies have identified multiple regions at 8q24 that confer susceptibility to many cancers. In our previous work, we showed that the colorectal cancer (CRC) risk variant rs6983267 at 8q24 resides within a TCF4 binding site at the MYC-335 enhancer, with the risk allele G having a stronger binding capacity and Wnt responsiveness. Here, we searched for other potential functional variants within MYC-335. Genetic variation within MYC-335 was determined in samples from individuals of European, African, and Asian descent, with emphasis on variants in putative transcription factor binding sites. A 2-bp GA deletion rs67491583 was found to affect a growth factor independent (GFI) binding site and was present only in individuals with African ancestry. Chromatin immunoprecipitation performed in heterozygous cells showed that the GA deletion had an ability to reduce binding of the transcriptional repressors GFI1 and GFI1b. Screening of 1,027 African American colorectal cancer cases and 1,773 healthy controls did not reveal evidence for association (odds ratio: 1.17, 95% confidence interval: 0.97-1.41, P = 0.095). In this study, rs67491583 was identified as another functional variant in the CRC-associated enhancer MYC-335, but further studies are needed to establish the role of rs67491583 in the colorectal cancer predisposition of African Americans. © 2012 Elsevier Inc.
  • Published In

  • Cancer Genetics  Journal
  • Digital Object Identifier (doi)

    Author List

  • Tuupanen S; Yan J; Turunen M; Gylfe AE; Kaasinen E; Li L; Eng C; Culver DA; Kalady MF; Pennison MJ
  • Start Page

  • 25
  • End Page

  • 33
  • Volume

  • 205
  • Issue

  • 1-2